“Clinical trials are one important area to watch for coming developments in AI and medical advancements.” said Karim Damji, SVP of Product Management & Marketing at Saama Technologies. While speaking to ITPro Today for their article – “Benefits of Artificial Intelligence in Healthcare: What’s Possible? What’s Next?”. He further elaborated on the importance of AI in drug development and spoke about DaLIA, Saama’s Deep learning intelligent assistant that uses NLP-NLU to facilitate a conversational experience with clinical trial data.
Read more about his thoughts here.